XLV250516C142000
- 0.10
- +0.05+100.00%
The Health Care Select Sector SPDR® Fund Newsroom
UnitedHealth's Troubles Get Worse, as 2025 Outlook Suspended and CEO Steps Down
Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock
What Does the Market Think About AbbVie?
Benzinga Market Summary: UnitedHealth Suspends FY25 Guidance, Apr. CPI Comes In Softer Than Expected, Trump Middle East On Watch
Johnson & Johnson Analyst Ratings
Biggest Stock Movers Tuesday: COIN, FSLR, UNH, and More
Wall Street Climbs As Inflation Cools, Nasdaq 100 Hits 10-Week Highs
4 Stocks to Watch on Tuesday: UNH, HOOD, SE and JD
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Leading And Lagging Sectors For May 13, 2025
Today's Pre-Market Movers and Top Ratings | UNH, COIN, SE and More
3D Systems, Rigetti Computing, UnitedHealth Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Key Inflation Data
US Morning News Call | U.S. Cuts China "De Minimis" Tariff to 54%
Merck Highlights MK-1084 Data From KANDLELIT-001 in KRAS G12C-Mutated Colorectal And Lung Cancers At ASCO 2025
UnitedHealth CEO Andrew Witty Steps Down For Personal Reasons; Chair Stephen Hemsley Takes Over As New Chief, Expects To Reurn To Growth In 2026
"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".
① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.
Magnificent Seven Gain $700B After US-China Slash Tariffs, Gold Crashes: What's Driving Markets Monday?
Amedisys Edges Lower on Report DOJ Initially Rejects Remedy in UnitedHealth
AbbVie Unusual Options Activity